TR199900596T2 - Otoimün hastaliklara karsi maddeler olarak proteinlerin kullanimi. - Google Patents

Otoimün hastaliklara karsi maddeler olarak proteinlerin kullanimi.

Info

Publication number
TR199900596T2
TR199900596T2 TR1999/00596T TR9900596T TR199900596T2 TR 199900596 T2 TR199900596 T2 TR 199900596T2 TR 1999/00596 T TR1999/00596 T TR 1999/00596T TR 9900596 T TR9900596 T TR 9900596T TR 199900596 T2 TR199900596 T2 TR 199900596T2
Authority
TR
Turkey
Prior art keywords
autoimmune diseases
proteins
agents against
against autoimmune
preparation
Prior art date
Application number
TR1999/00596T
Other languages
English (en)
Inventor
E. Panerai Alberto
Bartorelli Alberto
Original Assignee
Zetesis S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI961920 external-priority patent/IT1284554B1/it
Priority claimed from ITMI961919 external-priority patent/IT1284553B1/it
Priority claimed from ITMI961922 external-priority patent/IT1284556B1/it
Priority claimed from ITMI961921 external-priority patent/IT1284555B1/it
Application filed by Zetesis S.P.A. filed Critical Zetesis S.P.A.
Publication of TR199900596T2 publication Critical patent/TR199900596T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/846—Liver

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Otoimün hastaliklara karsi aktif tibbi maddelerin hazirlanmasi için, özelde ateroskleroz, arterit, multipl skleroz, seker hastaligina karsi tibbi maddelerin hazirlanmasi için, hayvan organlarindan perklorik asit ile ekstre edilen proteinlerin kullanimi.
TR1999/00596T 1996-09-18 1997-09-17 Otoimün hastaliklara karsi maddeler olarak proteinlerin kullanimi. TR199900596T2 (tr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITMI961920 IT1284554B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antiaterosclerotici
ITMI961919 IT1284553B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antiartritici
ITMI961922 IT1284556B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti contro la sclerosi multipla
ITMI961921 IT1284555B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antidiabetici

Publications (1)

Publication Number Publication Date
TR199900596T2 true TR199900596T2 (tr) 1999-06-21

Family

ID=27453037

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00596T TR199900596T2 (tr) 1996-09-18 1997-09-17 Otoimün hastaliklara karsi maddeler olarak proteinlerin kullanimi.

Country Status (22)

Country Link
US (2) US6468536B1 (tr)
EP (1) EP0928197B1 (tr)
JP (1) JP2001501925A (tr)
KR (1) KR20000036207A (tr)
CN (1) CN1151838C (tr)
AR (1) AR009952A1 (tr)
AT (1) ATE233569T1 (tr)
AU (1) AU723669B2 (tr)
BR (1) BR9711499A (tr)
CA (1) CA2266346A1 (tr)
CZ (1) CZ293926B6 (tr)
DE (1) DE69719525T2 (tr)
DK (1) DK0928197T3 (tr)
ES (1) ES2192669T3 (tr)
IL (1) IL129024A0 (tr)
NO (1) NO991175D0 (tr)
NZ (1) NZ334714A (tr)
PL (1) PL188746B1 (tr)
PT (1) PT928197E (tr)
RU (1) RU2196606C2 (tr)
TR (1) TR199900596T2 (tr)
WO (1) WO1998011909A1 (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3521382B2 (ja) 1997-02-27 2004-04-19 日本たばこ産業株式会社 細胞間接着及びシグナル伝達を媒介する細胞表面分子
US7112655B1 (en) 1997-02-27 2006-09-26 Japan Tobacco, Inc. JTT-1 protein and methods of inhibiting lymphocyte activation
IT1290828B1 (it) * 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
JP3871503B2 (ja) 1999-08-30 2007-01-24 日本たばこ産業株式会社 免疫性疾患治療剤
JP4210454B2 (ja) 2001-03-27 2009-01-21 日本たばこ産業株式会社 炎症性腸疾患治療剤
JP3597140B2 (ja) 2000-05-18 2004-12-02 日本たばこ産業株式会社 副刺激伝達分子ａｉｌｉｍに対するヒトモノクローナル抗体及びその医薬用途
AU2001278436A1 (en) * 2000-06-08 2001-12-17 Rakepoll Holding B.V. A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
JP4212278B2 (ja) 2001-03-01 2009-01-21 日本たばこ産業株式会社 移植片拒絶反応抑制剤
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
ITMI20010761A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 per il trattamento e la prevenzione dell'epatite cronica attiva
US20070275890A1 (en) * 2004-01-16 2007-11-29 Johnson Barbara J Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024247A (en) 1971-12-27 1977-05-17 Palolab Pharmaceuticals Corporation Composition and method of using a protein mixture derived from liver
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
FR2688227A1 (fr) 1992-03-04 1993-09-10 Inst Nat Sante Rech Med Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39

Also Published As

Publication number Publication date
CN1230892A (zh) 1999-10-06
CN1151838C (zh) 2004-06-02
AU723669B2 (en) 2000-08-31
ATE233569T1 (de) 2003-03-15
EP0928197A1 (en) 1999-07-14
CA2266346A1 (en) 1998-03-26
JP2001501925A (ja) 2001-02-13
NZ334714A (en) 2000-08-25
PL332282A1 (en) 1999-08-30
CZ293926B6 (cs) 2004-08-18
CZ91599A3 (cs) 1999-08-11
IL129024A0 (en) 2000-02-17
WO1998011909A1 (en) 1998-03-26
BR9711499A (pt) 1999-08-24
US20030108558A1 (en) 2003-06-12
PL188746B1 (pl) 2005-04-29
NO991175L (no) 1999-03-10
DE69719525T2 (de) 2003-10-02
US6468536B1 (en) 2002-10-22
KR20000036207A (ko) 2000-06-26
AR009952A1 (es) 2000-05-17
NO991175D0 (no) 1999-03-10
ES2192669T3 (es) 2003-10-16
AU4774797A (en) 1998-04-14
PT928197E (pt) 2003-06-30
RU2196606C2 (ru) 2003-01-20
DE69719525D1 (de) 2003-04-10
DK0928197T3 (da) 2003-06-23
EP0928197B1 (en) 2003-03-05

Similar Documents

Publication Publication Date Title
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
ES2109945T3 (es) Composiciones y procedimientos para identificar moleculas biologicamente activas.
ATE242633T1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
DE69832293D1 (de) Zubereitungen zur abgabe von negativ geladenen molekülen
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
ATE314092T1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
ATE249422T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
ATE243029T1 (de) Transdermales system zur verabreichung durch entepithelisierte haut
DE69805772D1 (de) Stabilisierte mischung auf fibrinogenbasis
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
EA200000190A1 (ru) Водные аэрозольные препараты, содержащие биологически активные макромолекулы, и способ получения соответствующих аэрозолей
EP1015008A4 (en) COMPOUNDS AND COMPOSITIONS FOR DELIVERY OF ACTIVE AGENTS
DE69830095D1 (de) Pharmazeutischer, kosmetischer oder dermo-pharmazeutischer Patch zur Verabreichung mehrerer verschiedenartiger Aktivstoffe
DE69512685D1 (de) Mittel zur verabreichung von wirksubstanzen an bzw. durch die haut
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
TR199901949T2 (tr) Lemfositik tümörler için çareler.
TR199900596T2 (tr) Otoimün hastaliklara karsi maddeler olarak proteinlerin kullanimi.
CA2132369A1 (en) Use for the Treatment of Mixed Skins, of an Effective Quantity of Active Substances
AR018489A1 (es) Uso de una celula realizada geneticamente que comprende dna que codifica una proteina de gen de activacion de linfocito 3 (lag-3) transmembrana y de dicha proteina para la fabricacion de un medicamento util para inducir la proteccion del rechazo de injerto y uso de moleculas antisentido de las misma
DE3789673D1 (de) Selbstansaugendes Zufuhrsystem zur Verabreichung eines Heilmittels.
ES2187648T3 (es) Metodo para la administracion de farmacos para terapia genica.
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
BR9305035A (pt) Agentes de curtimento e sua aplicaçáo
EP0783524A4 (en) PEPTIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE60125232D1 (de) Kleines säurelösliches sporenprotein und seine verwendungen